Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|May 12, 2006
Absence of BRAF gene mutation in non-melanoma skin tumorsMassimo Libra, Grazia Malaponte, Valentina Bevelacqua, et al.
Oncotarget|August 30, 2012
Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanomaValentina Bevelacqua, Ylenia Bevelacqua, Saverio Candido, et al.
International Journal of Molecular Medicine|July 26, 2006
Long pentraxin 3: a marker of inflammation in untreated psoriatic patientsValentina Bevelacqua, Massimo Libra, Maria C Mazzarino, et al.
Oncology Reports|April 6, 2006
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disordersMassimo Libra, Katia Mangano, Massimiliano Anzaldi, et al.
Atherosclerosis|January 22, 2003
Autosomal recessive hypercholesterolemia in a Sicilian kindred harboring the 432insA mutation of the ARH geneC M Barbagallo, G Emmanuele, A B Cefalù, et al.
Journal of Neuroimmunology|May 12, 2005
Osteopontin gene haplotypes correlate with multiple sclerosis development and progressionAnnalisa Chiocchetti, Cristoforo Comi, Manuela Indelicato, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 10, 2025
ApoE3 Christchurch and tau interaction as a protective mechanism against Alzheimer's diseasePaula Perez-Corredor, Said Arevalo-Alquichire, Randall C Mazzarino, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
<i>APOE3</i> Christchurch modulates tau phosphorylation and β-catenin/Wnt/Cadherin signaling in induced pluripotent stem cell-derived cerebral organoids from Alzheimer's casesR C Mazzarino, P Perez-Corredor, T E Vanderleest, et al.
Frontiers in Molecular Neuroscience|April 4, 2024
<i>APOE3</i> Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's casesPaula Perez-Corredor, Timothy E Vanderleest, Guido N Vacano, et al.
Oncotarget|September 26, 2012
Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy responseJames A McCubrey, Linda S Steelman, William H Chappell, et al.
Pageof 6